Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1

NCT04232566 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT04232566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04232566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity- AIM 1
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
February 20, 2022
Completion date
December 30, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic inflammation, nash - nonalcoholic steatohepatitis, obesity, morbid